These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17497545)

  • 21. Individual and system influences on waiting time for substance abuse treatment.
    Carr CJ; Xu J; Redko C; Lane DT; Rapp RC; Goris J; Carlson RG
    J Subst Abuse Treat; 2008 Mar; 34(2):192-201. PubMed ID: 17512159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Client and program characteristics associated with wait time to substance abuse treatment entry.
    Andrews CM; Shin HC; Marsh JC; Cao D
    Am J Drug Alcohol Abuse; 2013 Jan; 39(1):61-8. PubMed ID: 22783953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women and children last. Barriers to drug treatment for women.
    Brown L
    Health PAC Bull; 1992; 22(2):15-9. PubMed ID: 10171224
    [No Abstract]   [Full Text] [Related]  

  • 24. Controlled-release oxycodone admissions in public and private substance abuse treatment: associations with organizational characteristics.
    Knudsen HK; Ducharme LJ; Roman PM
    J Addict Dis; 2007; 26(1):41-50. PubMed ID: 17439867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incentives in a public addiction treatment system: Effects on waiting time and selection.
    Stewart MT; Reif S; Dana B; Nguyen A; Torres M; Davis MT; Ritter G; Hodgkin D; Horgan CM
    J Subst Abuse Treat; 2018 Dec; 95():1-8. PubMed ID: 30352665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure.
    Knudsen HK; Abraham AJ; Oser CB
    Eval Program Plann; 2011 Nov; 34(4):375-81. PubMed ID: 21371752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug treatment outcomes for persons on waiting lists.
    Chun J; Guydish JR; Silber E; Gleghorn A
    Am J Drug Alcohol Abuse; 2008; 34(5):526-33. PubMed ID: 18618338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient satisfaction, use of services, and one-year outcomes in publicly funded substance abuse treatment.
    Carlson MJ; Gabriel RM
    Psychiatr Serv; 2001 Sep; 52(9):1230-6. PubMed ID: 11533398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Policies and laws affecting Mexican-origin immigrant access and utilization of substance abuse treatment: obstacles to recovery and immigrant health.
    Moya EM; Shedlin MG
    Subst Use Misuse; 2008; 43(12-13):1747-69. PubMed ID: 19016163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thresholds in a low-threshold setting: an empirical study of barriers in a centre for people with drug problems and mental health disorders.
    Edland-Gryt M; Skatvedt AH
    Int J Drug Policy; 2013 May; 24(3):257-64. PubMed ID: 23036653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternity waiting homes in Ethiopia--three decades experience.
    Gaym A; Pearson L; Soe KW
    Ethiop Med J; 2012 Jul; 50(3):209-19. PubMed ID: 23409404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moving beyond access: towards a quality-orientated substance abuse treatment system in South Africa.
    Myers B; Petersen Z; Kader R; Parry CD
    S Afr Med J; 2012 Jun; 102(8):667-8. PubMed ID: 22831942
    [No Abstract]   [Full Text] [Related]  

  • 33. Medicaid eligibility and access to mental health services among adolescents in substance abuse treatment.
    Deck D; Ley KV
    Psychiatr Serv; 2006 Feb; 57(2):263-5. PubMed ID: 16452708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Michigan's substance abuse services: readiness for managed care.
    Stauffer M
    Behav Healthc Tomorrow; 1995; 4(4):57-8. PubMed ID: 10172404
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
    Friedmann PD; D'Aunno TA; Jin L; Alexander JA
    Health Serv Res; 2000 Jun; 35(2):443-65. PubMed ID: 10857471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Golden gate to health care for all? San Francisco's new universal-access program.
    Katz MH
    N Engl J Med; 2008 Jan; 358(4):327-9. PubMed ID: 18216352
    [No Abstract]   [Full Text] [Related]  

  • 37. The prospect of implementing a Safer Injection Facility in San Francisco: perspectives of community stakeholders.
    Wenger LD; Arreola SG; Kral AH
    Int J Drug Policy; 2011 May; 22(3):239-41. PubMed ID: 21334185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Walden House young adult HIV program.
    Greenberg B; Morris A; Nguyen H
    Psychiatr Serv; 2001 Jul; 52(7):973. PubMed ID: 11433120
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of substance use and mental distress among patients on waiting lists for substance use disorder treatment.
    Nordfjaern T
    J Psychoactive Drugs; 2013; 45(3):233-40. PubMed ID: 24175488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harlem service providers' perceptions of the impact of municipal policies on their clients with substance use problems.
    van Olphen J; Freudenberg N
    J Urban Health; 2004 Jun; 81(2):222-31. PubMed ID: 15136656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.